_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
Welcome to I.ON, the on-demand digital immunology programme designed to provide rheumatologists, dermatologists, immunologists and allergists treating PsO, chronic spontaneous urticaria, psoriatic arthritis and axial spondyloarthritis with first-class, digital, medical educational content.
What is axSpA?
axSpA is mainly characterised by inflammatory back pain, as well as involvement of the spine and sacroiliac joints. It also includes patients with:
- definite radiographic sacroiliitis observed on x-ray and meeting the modified New York (mNY) criteria, classified as having ankylosing spondylitis (AS); and
- patients without definite sacroiliitis detectable by radiography and not meeting mNY criteria, classified as having non-radiographic axSpA (nr-axSpA).1
axSpA is associated with a decrease in quality of life, work productivity and the burden of pain, fatigue and morning stiffness.1
axSpA, axial spondyloarthritis; Pso, psoriasis; mNY, modified New York.
Reference
- Bohn R, et al. Clin Exp Rheumatol 2018;36(2):263–274.